ArticleFrontiers in oncology2026
Diagnostic value of peripheral blood leukocyte parameters, NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, and NE-SFL, in lung cancer.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: We aimed to assess the diagnostic potential of six leukocyte parameters (NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, and NE-SFL) for lung cancer by analysing 423 patients, 39 benign cases, and 346 healthy controls. Methods: The results of these six leukocyte parameters were compared among groups using the Kruskal-Wallis H test. Multivariate logistic regression was used to analyze correlations between NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, NE-SFL, and lung cancer diagnosis. Patients were randomly grouped into training and testing sets, and nine machine-learning models (support vector machine, gradient boosting machine, artificial neural network, random forest [RF], extreme gradient boosting, K-nearest neighbor, adaptive boosting, light gradient boosting machine, and catboost) were built to compare the diagnostic performances. The DeLong test was adopted to compare the area under the receiver operating characteristic curve (AUC) values among nine machine learning models. Results: These six leukocyte parameter levels differed significantly between the lung cancer and control groups. Multivariate logistic regression revealed a strong predictive value of NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, and NE-SFL for lung cancer. NE-WX and NE-SFL were independent risk predictors. Receiver operating characteristic analysis revealed that MO-Y was the best diagnostic single indicator for lung cancer (AUC = 0.787, specificity=82.0%). The combination of LY-Y, MO-Y, MO-Z, and NE-SFL demonstrated superior diagnostic efficacy (AUC = 0.897, sensitivity=70.6%, specificity=78.9%, Youden index=0.495) compared with any single indicator. The RF model exhibited high consistency between predicted and actual values, demonstrating robust and reliable predictive performance in lung cancer diagnosis. MO-Y and MO-Z were the top predictive biomarkers with the strongest predictive value. Conclusions: NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, and NE-SFL may aid in diagnosis of lung cancer. The RF model demonstrates strong potential for lung cancer detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.